Literature DB >> 19330171

Drug repositioning summit: finding new routes to success.

Clara Campas1.   

Abstract

The Third Annual Drug Repositioning Summit 2008 was held at the Hyatt Harborside Hotel in Boston, Massachusetts, October 6-7, and focused on new strategies for drug repositioning. The meeting, organized by The Cambridge Healthtech Institute, brought together a panel of speakers from the industry and the academia, who discussed and proposed new routes for success in drug repositioning based on their own experience in the field. This meeting report summarizes the most relevant presentations and issues discussed. Copyright 2009 Prous Science, S.A.U. or its licensors. All rights reserved.

Mesh:

Year:  2009        PMID: 19330171     DOI: 10.1358/dnp.2009.22.2.1334453

Source DB:  PubMed          Journal:  Drug News Perspect        ISSN: 0214-0934


  3 in total

1.  Metformin intake is associated with better survival in ovarian cancer: a case-control study.

Authors:  Sanjeev Kumar; Alexandra Meuter; Prabin Thapa; Carrie Langstraat; Shailendra Giri; Jeremy Chien; Ramandeep Rattan; William Cliby; Viji Shridhar
Journal:  Cancer       Date:  2012-12-03       Impact factor: 6.860

2.  Phenotypic connections in surprising places.

Authors:  Bolan Linghu; Charles DeLisi
Journal:  Genome Biol       Date:  2010-04-28       Impact factor: 13.583

3.  Metformin and epithelial ovarian cancer therapeutics.

Authors:  Seema Patel; Lalit Kumar; Neeta Singh
Journal:  Cell Oncol (Dordr)       Date:  2015-08-13       Impact factor: 6.730

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.